ProKidney Q2 EPS $(0.12) Down From $(0.09) YoY
Portfolio Pulse from Benzinga Newsdesk
ProKidney (NASDAQ:PROK) reported Q2 losses of $(0.12) per share, a 33.33% increase in losses from $(0.09) per share in the same period last year.
August 10, 2023 | 9:08 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ProKidney's Q2 losses per share increased by 33.33% YoY, which may negatively impact investor sentiment.
ProKidney reported an increase in losses per share for Q2, which is a negative indicator of the company's financial health. This could lead to a decrease in investor confidence and potentially a drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100